share_log

B of A Securities Reinstates Buy on Acumen Pharmaceuticals, Announces $14 Price Target

B of A Securities Reinstates Buy on Acumen Pharmaceuticals, Announces $14 Price Target

B of A 证券恢复对Acumen Pharmicals的买入,宣布目标股价为14美元
Benzinga ·  2023/07/20 06:52

B of A Securities analyst Geoff Meacham reinstates Acumen Pharmaceuticals (NASDAQ:ABOS) with a Buy and announces $14 price target.

B of A Securities分析师杰夫·米查姆以买入恢复Acumen Pharmicals(纳斯达克股票代码:ABOS),并宣布目标股价为14美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发